Patrick Miossec, Paris FR
Patrick Miossec, Paris FR
Patent application number | Description | Published |
---|---|---|
20100273872 | USE OF 4-OXOBUTANOIC ACID DERIVATIVES IN THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH IMMUNOLOGICAL DISORDERS - The present invention relates to the use of a 4-oxobutanoic acid derivative for the preparation of a pharmaceutical composition for the treatment of pathologies associated with immunological disorders. | 10-28-2010 |
20120277147 | PREVENTION OF HYPOGLYCAEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS - A method for the prevention of hypoglycaemia in diabetes mellitus type 2 comprising administering (a) desPro | 11-01-2012 |
20130005649 | PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON THERAPY TO BASAL INSULIN - The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients. | 01-03-2013 |
20130023467 | PHARMACEUTICAL COMBINATION FOR USE IN INDUCING WEIGHT LOSS IN DIABETES TYPE 2 PATIENTS OR/AND FOR PREVENTING WEIGHT GAIN IN DIABETES TYPE 2 PATIENTS - The present invention refers to a pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients. | 01-24-2013 |
20130040878 | PHARMACEUTICAL COMBINATION FOR USE IN THE TREATMENT OF DIABETES TYPE 2 PATIENTS - The present invention refers to a pharmaceutical combination for use in the treatment of diabetes type 2 patients. | 02-14-2013 |
20130065828 | PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN DIABETES TYPE 2 PATIENTS - The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients. | 03-14-2013 |
20130085102 | PREVENTION OF HYPOGLYCEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS - A method for the prevention of hypoglycaemia in diabetes mellitus type 2 comprising administering | 04-04-2013 |
20130203666 | PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN DIABETES TYPE 2 PATIENTS - The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients. | 08-08-2013 |
20140148384 | USE OF AVE0010 FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 - The present invention refers to the use of Lixisenatide or/and a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of diabetes mellitus type 2, for inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients. | 05-29-2014 |